Rank #1864BYSI

BeyondSpring, Inc.

$1.32

0.00% (Daily)

Market Cap

$54.28M

Revenue

$N/A

Rank by MCap

#1864

Sector

Healthcare

Industry

Biotechnology

CEO

Dr. Lan Huang Ph.D.

Headquarters

Florham Park, NJ

Employees

About BeyondSpring, Inc.

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. It operates through two segments: Plinabulin pipeline and TPD platform. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia. It is also developing...